Proteus Syndrome
A rare disorder of progressive, uneven tissue overgrowth
Quick Facts
- Type: Rare overgrowth (genetic) disorder
- Cause: A change in the AKT1 gene that arises after conception
- Hallmark: Asymmetric, progressive overgrowth of tissues
- Inheritance: Not inherited; not passed from parent to child
Overview
Proteus syndrome is a very rare condition in which bones, skin, fatty tissue, and other parts of the body grow too much. The overgrowth is typically asymmetric, meaning it affects some areas while sparing others, and it tends to get worse over time, especially during childhood.
Babies with Proteus syndrome usually look unaffected at birth, with overgrowth becoming noticeable in the toddler years and progressing through childhood. The condition is named after the Greek god Proteus, who could change his shape, because its features vary so widely from one person to another.
Proteus syndrome is extremely rare, and no two people are affected in quite the same way. Because the overgrowth is uneven and changes over time, care must be tailored to each person and reviewed regularly. Many people with the condition need coordinated input from several specialists throughout their lives, and early recognition allows complications to be anticipated and managed before they become serious.
Symptoms
Signs differ greatly between individuals but may include:
- Overgrowth of bones, leading to limbs, hands, or feet of different sizes
- Thickened, ridged skin growths, often on the soles of the feet (cerebriform connective tissue nevi)
- Curvature of the spine (scoliosis) from uneven bone growth
- Abnormal fatty growths or areas where fat is reduced
- Blood vessel malformations
Some people have an increased tendency to form blood clots, which can be serious. Overgrowth is usually progressive, so features become more pronounced over the years.
Causes
Proteus syndrome is caused by a change (mutation) in a gene called AKT1, which helps control cell growth and division. Importantly, this change is not present in every cell of the body. It occurs after conception, during early development, so only some cells carry it. This is called a mosaic mutation.
Because only some cells are affected, overgrowth happens in a patchy, uneven pattern. The mutation is not inherited from a parent and is not passed on to a person's children. It arises by chance, and nothing a parent did causes it.
Risk Factors
Proteus syndrome occurs randomly. There are no known lifestyle, environmental, or inherited risk factors that make it more likely. Because the gene change happens by chance during early development:
- It does not run in families
- It is not linked to anything the parents did before or during pregnancy
- Both sexes and all backgrounds can be affected equally
Diagnosis
Diagnosis is based on the pattern of overgrowth and can be confirmed with genetic testing:
- Clinical assessment: Doctors look for progressive, asymmetric overgrowth and characteristic skin and bone changes against established diagnostic criteria.
- Imaging: X-rays, CT, or MRI scans show the extent of bone and tissue overgrowth and help with surgical planning.
- Genetic testing: Testing tissue from an affected area can detect the AKT1 change. Because the mutation is mosaic, a sample from overgrown tissue is more informative than blood.
Treatment
There is no cure, so treatment focuses on managing symptoms and complications with a team of specialists.
- Orthopedic care: Surgery may correct or limit overgrowth, manage scoliosis, and address differences in limb length.
- Skin and soft-tissue surgery: Problematic growths can be removed to improve comfort and function.
- Clot prevention: Because the risk of blood clots is higher, doctors watch for clots and may take preventive steps around surgery.
- Supportive care: Physical therapy, mobility aids, and emotional support help with daily function and well-being.
Research into medicines that target the AKT1 pathway is ongoing, and care should be guided by specialists familiar with the condition. Because the overgrowth keeps changing, treatment is rarely a one-time event; instead, it is an ongoing process of monitoring, planning, and adjusting care as the person grows and their needs change over time.
When to See a Doctor
A child with progressive, uneven overgrowth of limbs, skin, or other tissues should be evaluated by specialists. Seek prompt medical attention for warning signs of a blood clot, which is an emergency:
- Sudden swelling, pain, warmth, or redness in a leg or arm
- Sudden shortness of breath, chest pain, or coughing up blood
Call emergency services right away if these symptoms occur, as a clot that travels to the lungs can be life-threatening.
Frequently Asked Questions
Is Proteus syndrome inherited?
No. It is caused by a gene change that arises by chance after conception, so only some cells carry it. It is not passed from parent to child and does not run in families.
When does Proteus syndrome usually become noticeable?
Babies usually appear unaffected at birth. Overgrowth typically becomes apparent in the toddler years and progresses through childhood, with features becoming more pronounced over time.
Is there a cure for Proteus syndrome?
There is no cure. Treatment focuses on managing overgrowth and complications through orthopedic surgery, skin surgery, clot prevention, and supportive care from a specialist team. Research into targeted medicines is ongoing.
Why are blood clots a concern in Proteus syndrome?
People with Proteus syndrome have a higher tendency to form blood clots, which can be dangerous, especially around surgery. Sudden leg swelling, chest pain, or shortness of breath are emergencies that need immediate care.
How is Proteus syndrome diagnosed?
Doctors diagnose it from the pattern of progressive, asymmetric overgrowth and characteristic skin and bone changes. Genetic testing of affected tissue can confirm the AKT1 gene change.
References
- National Human Genome Research Institute (NHGRI). Proteus Syndrome.
- MedlinePlus, U.S. National Library of Medicine. Proteus syndrome.
- Genetic and Rare Diseases Information Center (GARD). Proteus syndrome.
- National Organization for Rare Disorders (NORD). Proteus Syndrome.